Register to get unlimited access to all of Citywire’s fund manager database. Registration is free and only takes a minute.

Polar Capital Biotechnology R USD

Ranked 4 out of 37 in - Biotechnology over 12 months
All calculations are in USD unless stated

Managed by

David Pinniger

David Pinniger joined Polar Capital in 2013 and is manager of the Polar Capital Biotechnology Fund. Prior to joining Polar Capital, he worked at SV Life Sciences, Abingworth and Morgan Stanley. David holds a first class honours degree in Human Sciences from the University of Oxford and is a CFA charterholder.

Objective

The investment objective of the Fund is to preserve capital and achieve long term capital appreciation.The Fund will seek to achieve its investment objective by investing in a globally diversified portfolio of biotechnology, diagnostics and life sciences tools companies.

Showing fund performance globally. You can view performance in individual jurisdictions.

Performance

Biotechnology over : 30/06/2016 - 30/06/2017

Total Return

Quarterly Performance

to 30/06/2017 Annual Q1 Q2 Q3 Q4
2017 14.6% 4.9%
2016 -7.9% -18.9% 2.7% 13.4% -2.5%
2015 12.4% 13.6% 7.7% -16.5% 9.9%
2014 47.5% 18.3% 4.7% 5.7% 12.6%

Month by Month Performance

Returns Vs Risk

Asset Allocation

Breakdown

30/04/2017

Top 10 Holdings

Stock Size
Celgene Corp ORD 6.76
Regeneron Pharmaceuticals Inc ORD 5.41
Incyte Corp ORD 4.89
USD Cash 4.60
Genmab A/S ORD 4.21
Eli Lilly and Co ORD 3.98
Biogen Inc ORD 3.78
Gilead Sciences Inc ORD 3.74
ACADIA Pharmaceuticals Inc ORD 3.64
Biomarin Pharmaceutical Inc ORD 3.19
30/04/2017

Registered For Sale In

  1. Austria
  2. Belgium
  3. Denmark
  4. Finland
  5. France
  6. Germany
  7. Guernsey
  8. Ireland
  9. Italy
  10. Jersey
  11. Luxembourg
  12. Netherlands
  13. Norway
  14. Singapore
  15. Spain
  16. Sweden
  17. Switzerland
  18. United Kingdom

Fund Info

  • Launch date31/10/2013
  • Share Class size189Mn
  • Base currencyUSD
  • ISIN IE00B3XLHR60

Purchase Info

  • Min. initial investment0
  • Min. regular additional investment0

Charges

  • Annual management1.50%
  • Initial investment5

Related News

Selector snapshot: fantastic boutiques and where to find them

The latest one-to-one delves into uncovering lesser-known firms from across Europe.

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in USD).